Health Care [ 12/12 ] | Life Sciences Tools & Services [ 71/74 ]
NASDAQ | Common Stock
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia.
The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas.
It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services.
In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials.
Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Jul 22, 24 | 2.75 Increased by +42.49% | 2.54 Increased by +8.27% |
| Apr 22, 24 | 3.20 Increased by +40.97% | 2.47 Increased by +29.55% |
| Feb 12, 24 | 2.46 Increased by +16.04% | 2.22 Increased by +10.81% |
| Oct 23, 23 | 2.22 Increased by +8.29% | 2.05 Increased by +8.29% |
| Jul 24, 23 | 1.93 Increased by +32.19% | 1.91 Increased by +1.05% |
| Apr 24, 23 | 2.27 Increased by +34.32% | 1.80 Increased by +26.11% |
| Feb 13, 23 | 2.12 Increased by +60.61% | 1.79 Increased by +18.44% |
| Oct 24, 22 | 2.05 Increased by +58.91% | 1.47 Increased by +39.46% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Sep 30, 24 | 533.32 M Increased by +8.29% | 96.43 M Increased by +36.77% | Increased by +18.08% Increased by +26.30% |
| Jun 30, 24 | 528.10 M Increased by +14.59% | 88.35 M Increased by +44.68% | Increased by +16.73% Increased by +26.26% |
| Mar 31, 24 | 511.04 M Increased by +17.73% | 102.55 M Increased by +40.68% | Increased by +20.07% Increased by +19.49% |
| Dec 31, 23 | 498.40 M Increased by +26.47% | 78.25 M Increased by +13.94% | Increased by +15.70% Decreased by -9.90% |
| Sep 30, 23 | 492.50 M Increased by +28.34% | 70.50 M Increased by +6.85% | Increased by +14.32% Decreased by -16.75% |
| Jun 30, 23 | 460.87 M Increased by +31.22% | 61.07 M Increased by +23.80% | Increased by +13.25% Decreased by -5.66% |
| Mar 31, 23 | 434.07 M Increased by +31.16% | 72.89 M Increased by +18.96% | Increased by +16.79% Decreased by -9.30% |
| Dec 31, 22 | 394.10 M Increased by +27.72% | 68.67 M Increased by +37.35% | Increased by +17.42% Increased by +7.54% |